Protocol number:
MO25616
Title of Study:
A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Sponsor:
Hoffmann-La Roche
Company division:
Pharmaceutical
Product name:
vismodegib
Therapeutic area:
  • Basal Cell Carcinoma
Clinical study summary:
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.
Phase of development:
II
Date of report:
To be Published

Click here for the protocol registry listing of this trial.